BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing
Release Date: December 2013
This topic is in the process of being updated. Please go to the Update in Progress section to see the latest documents available.
Summary of Recommendations and Evidence
|Women who have Family Members with Breast, Ovarian, Tubal, or Peritoneal Cancer|
The USPSTF recommends that primary care providers screen women who have family members with breast, ovarian, tubal, or peritoneal cancer with 1 of several screening tools designed to identify a family history that may be associated with an increased risk for potentially harmful mutations in breast cancer susceptibility genes (BRCA1 or BRCA2). Women with positive screening results should receive genetic counseling and, if indicated after counseling, BRCA testing.
|Women Whose Family History is not Associated with an Increased Risk|
The USPSTF recommends against routine genetic counseling or BRCA testing for women whose family history is not associated with an increased risk for potentially harmful mutations in the BRCA1 or BRCA2 genes.
Related Information for Consumers
Related Information for Health Professionals
- Breast Cancer Risk Assessment Tool from the National Cancer Institute
- Recommendations from The Community Preventive Services Task Force on Promoting Cancer Screening
- Cancer Control P.L.A.N.E.T.
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women - Clinical Summary of USPSTF Recommendation, 2013
Internet Citation: Final Update Summary: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing. U.S. Preventive Services Task Force. September 2016.